You are here

Bioiberica receives authorisation for Mobilee® as novel food ingredient in Brazil

14 Jan 2020
  • Mobilee® is a patented naturally-derived ingredient that contributes to maintaining joint health and muscular function
  • Its nutritional characteristics and safety have been tested in six preclinical studies and five randomised clinical studies over twelve years
  • Mobilee® is authorised as an ingredient for food supplements and functional foods by the main healthcare authorities worldwide
  • Brazil is a strategic market for Bioiberica, where the company is already a market leader in the joint health segment with its native type II collagen, b-2Cool®

The Health Regulatory Agency (ANVISA) of the Brazilian Ministry of Health has provided marketing authorisation for Mobilee® as a novel food ingredient in the country. Part of Bioiberica’s branded ingredients portfolio for healthcare, Mobilee® is a patented ingredient derived from rooster comb extract that is rich in hyaluronic acid. Proven to contribute to maintaining joint health and muscular function, Mobilee® contains a high concentration of hyaluronic acid and other components, including collagen and polysaccharides. Its nutritional characteristics and safety have been tested in six preclinical trials and five randomised clinical trials over the last twelve years. Now available for use in food applications across Brazil, manufacturers across the country are able to meet growing consumer demand for products that support joint health and mobility.

Dr Daniel Martínez, Head of Human Health R&D at Bioiberica, explains: “Mobilee® is an innovative product that is naturally absorbed by the human body. Thanks to the synergy of its individual components - hyaluronic acid, collagen and polysaccharides - the benefits Mobilee® can offer, go far beyond the advantages offered by hyaluronic acid alone. Taking just 80 mg per day for at least two months preserves joint health and muscular function.

Mobilee® is authorised as an ingredient for food supplements and functional foods by the main competent authorities worldwide. These include the European Union (Novel Food), United States (GRAS status), Canada (medicinal supplement), Australia and New Zealand (medicinal supplement and non-traditional ingredient for use in functional foods), India (functional ingredient) and Indonesia and Taiwan (nutritional supplement).

Jaume Reguant, Director of Healthcare at Bioiberica, adds: “Brazil is a key market for Bioiberica in the area of joint health, where we are already market leader with our native type II collagen, b-2Cool®, thanks to the strategic partnership with our Brazilian partner, Ayalla. Together with them, we will continue to meet the needs of thousands of people who look to maintain healthy joints.”

Bioiberica is a worldwide leader in the life sciences sector, committed to improving the health and well-being of people, animals and plants. Bioiberica is the leading manufacturer of heparin's pharmaceutical active substance and the world bellwether in the research, production, and sale of other drugs and ingredients like chondroitin sulfate, glucosamine, hyaluronic acid, native type II collagen, and thyroid extracts. 

Related News

29 May 2022

With World Digestive Health Day around, shortly followed by World Allergy Awareness Week (5-11 June), we’re exploring the increasing relevance of a relatively unknown digestive health disorder – histamine intolerance.

25 May 2022

New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.